Venture Capital Investors in AI & Technology

Angelini Ventures is the venture capital arm of Angelini Industries, investing in innovative startups across biotech and digital health. The firm focuses on advancing healthcare through breakthrough therapies, medical technologies, and data-driven solutions. With a global investment strategy, Angelini Ventures backs early and growth-stage companies working to improve patient outcomes and transform how diseases are treated and managed. The firm combines capital with deep industry expertise and strategic support from its parent organization.

Avaana Capital is an India-based venture capital firm investing in climate and sustainability solutions across sectors such as energy, mobility, agriculture, and industrial systems. The firm backs early-stage founders building scalable technologies that address climate change while driving economic growth. Co-founded by Anjali Bansal, Avaana combines deep operational expertise with a strong network across government, corporates, and global investors. The firm focuses on enabling the transition to a low-carbon economy through innovation and technology.

Cerulean Ventures is a $10 million pre-seed venture capital firm that backs founders building asset-light, rapid scaling software companies focused on climate solutions. They specifically target companies applying AI to build exponential solutions for nature and climate change. Their mission is to bring climate solutions to market quickly while fighting greenwashing and moving the climate economy beyond the green premium. Unlike traditional climate investors who focus on niche markets with green premiums or first-of-a-kind moonshots with decades-long timelines, Cerulean takes a different approach by identifying systemic leverage points where proprietary data, compute, AI scaling, and fintech solutions can rapidly scale. Cerulean matters in the ecosystem because they focus on transforming large economic sectors that have been resistant to digital transformation, including mining, niche manufacturing, soft tropical commodities, pharma supply chains, and emerging markets of natural capital and biodiversity. They position themselves as addressing the gap in climate investing by targeting systemic change rather than status quo business model disruptions.

Oncology Ventures is a healthcare-focused venture capital firm investing in commercially validated startups transforming cancer care through data, technology, artificial intelligence, and healthcare infrastructure innovation. Founded by cancer survivor Ben Freeberg, the firm focuses on solving systemic challenges across the oncology ecosystem, from early detection and diagnostics to patient navigation, care delivery, and survivorship. The firm backs companies building the non-drug infrastructure of cancer care, helping improve outcomes, reduce inefficiencies, and increase access to evidence-based treatment for patients across the healthcare system.

Pay it Forward Ventures (PIF) builds better lives for billions by investing in source-solving rather than symptom-solving. They fund and found ventures that create new paradigms across financial technology, health, energy, and digital infrastructure — and donate 20% of GP profits to philanthropy because they believe in paying it forward.

Praxis is a global venture-building ecosystem supporting entrepreneurs, nonprofits, investors, and culture makers motivated by faith to address major social and cultural challenges. Through accelerators, fellowships, mentorship, and community-building programs, Praxis helps founders build “redemptive ventures” focused on renewal, restoration, and long-term societal impact. The organization supports both for-profit and nonprofit ventures across sectors including education, healthcare, technology, community development, social innovation, and ethical entrepreneurship.

ReGen Ventures is an impact-focused venture capital firm that invests in foundational regenerative technologies designed to power a future of abundance. They focus on four core investment areas: clean energy, planetary intelligence, programmable matter, and adaptive robotics, partnering with founders who are building transformative technologies from the atomic to planetary scale. The firm operates with a mission to reimagine the world by supporting technologies that make regeneration inevitable, enabling infinite growth and prosperity on a finite planet. They take a hands-on approach with founders, providing comprehensive support that ranges from business modeling to personal wellness, emphasizing long-term sustainable returns over short-term wins. ReGen Ventures positions itself as an innovator in the investment space, paving a new path for what investments should be by focusing on root causes rather than symptoms of environmental challenges. They are building what they call a "ReGenerative Future" where climate change is reframed as an opportunity for transformation, backing founders with unreasonable ambition who alter understanding of what's possible in addressing planetary challenges.

SOSV is a global venture capital firm and accelerator founded in 1995, operating one of the most active deep tech and life sciences investment programs in the world. The firm runs multiple accelerator programs, including HAX for hardware and robotics, IndieBio for life sciences and biotech, and Orbit for climate and sustainability — providing intensive company-building support alongside early-stage capital. With over $1.5 billion in AUM and a portfolio exceeding 1,000 companies across more than 70 countries, SOSV occupies a distinctive position in the venture landscape: a programmatic investor that takes companies from idea stage through to growth and beyond. The firm's accelerator model means it is often the first institutional check into a company, with follow-on capability through later rounds. SOSV has a strong impact orientation across its portfolio, with climate, food systems, health, and sustainability representing a significant share of its investments. Its programs in particular have become known as launchpads for companies working on hard scientific and engineering problems that require more than capital to succeed.